Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-18

Clinical Trial Update: Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2) [Phase 3]

View source ↗

Summary

Phase 3 trial examining maternal DHA supplementation and offspring neurodevelopment completed in India.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DHA (Docosahexaenoic acid)

Snippet

Sponsor: Public Health Foundation of India | Conditions: Pregnancy | Phase 3 | Status: COMPLETED